ArticlePharmacoepidemiology and drug safety2022
Real-world data: Assessing electronic health records and medical claims data to support regulatory decision-making for drug and biological products.
Article in Pharmacoepidemiology and drug safety, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 143 papers, 6 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
143 citing papers in PubMed, 6 syntheses or guidelines pooled it.
- A Systematic Review to Summarize and Critically Appraise Existing Phenotype Libraries Using Electronic Health Records.Pharmacoepidemiology and drug safety · 2026Pooled it
- Metabolic dysfunction, antidiabetic drugs, and asthma: bibliometric evidence, emerging trends, and translational frontiers from 2006 to 2025.Frontiers in endocrinology · 2026Pooled it
- Faster but Not Truer, Part 1: A Systematic Scoping Review of Artificial Intelligence in Health Economics and Outcomes Research.Journal of health economics and outcomes research · 2026Pooled it
- Pooled it
- Challenges for Data Quality in the Clinical Data Life Cycle: Systematic Review.Journal of medical Internet research · 2025Pooled it
- Use of external control arms in immune-mediated inflammatory diseases: a systematic review.BMJ open · 2023Pooled it
- Investigational Use of Real-World Data as a Hybrid Control in Pancreatic Ductal Adenocarcinoma From the Randomized Phase Ib/II MORPHEUS Trial.Clinical pharmacology and therapeutics · 2025Trial
- Temporal Trends in Clinical Evidence of 5-Year Survival Within Electronic Health Records Among Patients With Early-Stage Colon Cancer Managed With Laparoscopy-Assisted Colectomy vs Open Colectomy.JAMA network open · 2022Trial
- Overview of Regulatory Guidelines Related to Methods and Models for Small Populations.Clinical pharmacology and therapeutics · 2026Review
- Target trial emulation studies in oncology: a comprehensive analysis.The oncologist · 2026Article
- Considerations for the Integration of Clinical Trials and Real-World Data.Clinical pharmacology and therapeutics · 2026Review
- Recommendations for generating real-world evidence with regulatory-grade relevance and reliability.International journal of clinical oncology · 2026Review
- A Practical Guide to Implementing Real-World Evidence as Primary Basis for Approval and Label Expansion.Clinical pharmacology and therapeutics · 2026Article
- Computable longitudinal patient journeys from structured and unstructured EHR data.Nature medicine · 2026Article
- Quantitative bias analyses to address measurement error in time-to-event endpoints.American journal of epidemiology · 2026Article
- Respiratory Syncytial Virus Vaccine Effectiveness Among US Older Adults, 2023-2024 Season.JAMA network open · 2026Article
- Validation of Claims-Based Algorithms for Identifying Congenital Urinary Tract, Genital, Gastrointestinal, and Musculoskeletal Malformations.Pharmacoepidemiology and drug safety · 2026Article
- Characteristics and Future Perspectives of Available Electronic Health Record Databases in Japan.Drugs - real world outcomes · 2026Review
- Risk of Bias Associated with Varying Sampling Strategies for External Comparator Cohorts for Single-Arm Trials: Insights from Aggressive Lymphoma.Clinical pharmacology and therapeutics · 2026Article
- Computable phenotypes for research using real-world data: experiences from the NIH pragmatic trials collaboratory.JAMIA open · 2026Article
83 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.